Performance of Activities. The Nurse Representative shall notify her/his immediate supervisor prior to performing permitted Nurse Representative duties on work time. If, in the supervisor’s discretion, the permitted activity would interfere with the work of the Nurse Representative or other employees, the Nurse Representative will arrange with the responsible supervisor(s) for a mutually satisfactory time to perform the requested activity.
Performance of Activities. Data Recipient may use and disclose the Limited Data Set only (1) in the performance of the research activities (the “Activities”) as detailed in Attachment B to this Agreement, or (2) subject to the provisions of Section 3.d, as otherwise required by law.
Performance of Activities. Data User may use and disclose the Limited Data Set received from Covered Entity only in connection with the performance of research activities public health activities health care operations Description of permitted activities: Data User shall limit the use or receipt of the Limited Data Set to the following individuals or classes of individuals who need the Limited Data Set for the performance of the Activities: For HIV-related information, Data User hereby acknowledges and agrees that Covered Entity has notified Data User that it is required to comply with the confidentiality, disclosure and re-disclosure requirements of 10 NYCRR Part 63.
Performance of Activities. Data User may use and disclose the Limited Data Set received from Covered Entity only in connection with the performance of the activities described on the “Request to Access Health Information by Use of a Limited Data Set” attached to this Agreement (the “Activities”). Data User shall limit the use or receipt of the Limited Data Set to the individuals or classes of individuals described on the attached “Request to Access Health Information by Use of a Limited Data Set” who need the Limited Data Set for the performance of the Activities.
Performance of Activities. In the event of a termination, (a) Investigator will immediately stop enrolling subjects into the Study and cease conducting Study procedures and treatment with the Study Drug on subjects already entered into the Study, to the extent medically advisable, and (b) Institution and/or Investigator will (i) furnish to Sponsor all Study Data and all CRFs, completed or partially complete, as of the effective date of termination, and (ii) return to Sponsor all Materials (defined below) that were furnished to Institution or Investigator, in accordance with Sponsor’s instruction, except for records or samples which the Institution and/or Investigator is required by law to retain. Within thirty (30) days of termination of this Agreement or completion of the Study (whichever comes first), (b) Provádění aktivit. V případě ukončení (a) Zkoušející okamžitě zastaví nábor subjektů do Studie a ukončí provádění studijních postupů a léčby Hodnoceným přípravkem u subjektů, které již byly zařazeny do Studie v míře z lékařského hlediska vhodné, a (b) Poskytovatel zdravotních služeb a/nebo Zkoušející (i) poskytne Zadavateli všechna Studijní data a všechny CRF, které budou vyplněny nebo částečně vyplněny, od data platnosti ukončení, a (ii) vrátí Zadavateli všechny Materiály (definované níže), které byly dodány Poskytovateli zdravotních služeb nebo Zkoušejícímu, v souladu s instrukcemi Zadavatele, kromě záznamů nebo vzorků, které musí Poskytovatel zdravotních služeb a/nebo Zkoušející uchovat podle zákona. Během třiceti (30) dnů od ukončení této Smlouvy nebo dokončení Studie (podle toho, co nastane jako první) předloží Investigator will submit final written reports to Sponsor, which reports shall be consistent with industry standards and any criteria or requirements therefore specified in the Protocol. After termination of this Agreement or suspension of the Study at the Institution for any reason, all Parties shall continue activities under this Agreement solely as deemed necessary by mutual written agreement of the Parties based on reasonable medical judgment to protect the health of subjects participating in the Study. This Section 2.5 survives termination of this Agreement. Zkoušející Zadavateli závěrečné písemné zprávy, které budou odpovídat oborovým standardům a všem kritériím nebo požadavkům, které jsou za tímto účelem specifikovány v Protokolu. Po ukončení této Smlouvy nebo po zastavení Studie ve Zdravotnickém zařízení z jakéhokoli důvodu budou všechny Smluvní strany pokračo...
Performance of Activities. Data User may use and disclose the Limited Data Set received from Covered Entity only in connection with the performance of the: [check appropriate box] research activities, public health activities, health care operations described below: [describe] .
Performance of Activities. Data User may use and disclose the Limited Data Set only in connection with the performance of the research activities described in the Protocol, entitled, (the “Activities”).
Performance of Activities. Data User may use and disclose the Limited Data Set received from Covered Entity only in connection with the performance of Burn Model System research activities. Data User shall limit the use or receipt of the Limited Data Set to members of the Burn Model Systems research team at [name of Burn Model System] and certain individuals within these institutions who are responsible for overseeing research activities.
Performance of Activities. Data User may use and disclose the Data Set received from Covered Entity only in connection with the performance of the following research activities: Completion of the Specific Aims of the XXX initiative and any adjunct research activities generated by the XXX initiative.
Performance of Activities. (a) Performance of the Activities shall be coordinated with a representative of Owner to minimize unreasonable interference with normal operation of the Premises. All Activities at the Premises shall be performed during normal business hours or at such other times and on such days of the week as Owner shall determine in its reasonable discretion and shall be performed in a manner that will not have any material adverse effect on Owner, or any other person or entity granted rights of use and occupancy through Owner, their respective agents, employees or invitees, or all of them.
